Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
ESMO Open|January 28, 2026
Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational studyH A Jung, R Merkin, A L Feng, et al.European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapyS Park, M-H Lee, M Seong, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trialS-H Lee, J-K Lee, M-J Ahn, et al.ESMO Open|February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II studyS Park, J-M Sun, Y-L Choi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2020
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patientsJ H Shim, H S Kim, H Cha, et al.Molecular Cell|August 14, 1998
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factorsC D Laherty, A N Billin, R M Lavinsky, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancerS Park, I R Kim, K K Baek, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.Pageof 8